Since its mid-2022 launch, the Tesla Model Y has dominated EV sales, driven by affordable prices, easy charging and dynamic ...

In an 8-K filing submitted to the SEC today, Plug Power said that it expects gross margins to be stable on an annual basis ...

Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies.